Pacific Edge rises as wider sharemarket stutters

Pacific Edge rises as wider sharemarket stutters
Pacific Edge's chances of a lifeline with Obamacare lifted its share price. (Image: Getty)
Graham Skellern
Pacific Edge made a rapid recovery, rising more than 110% after receiving a reprieve on funding for its Cxbladder tests in the United States, while an uncertain New Zealand sharemarket had its first fall in eight trading days.The S&P/NZX 50 Index wavered in the afternoon and closed at 11,959.33, down 43.13 points or 0.36% after reaching an intraday high of 12,055.2.Market sentiment also softened across the Tasman with the Australian S&P/ASX 200 Index falling 1.29% to 7159.6 points by 6pm NZ time.There were 53 gainers and 79 decliners on...

More Markets

Tower's risk-based revolution
Markets

Tower's risk-based revolution

It's one of the few insurers in Australasia growing. How?

RBNZ plan to cut AT1 capital layer wins cautious lender support
Finance

RBNZ plan to cut AT1 capital layer wins cautious lender support

Proposal to pare AT1 capital from prudential stacks wins cautious support from lenders.

NZ sharemarket starts week down 0.8%
Markets Market Close

NZ sharemarket starts week down 0.8%

The S&P/NZX 50 Index closed at 13,351.92, down 115.34 points or 0.86%.

Graham Skellern 13 Oct 2025
ANZ NZ continues to hold market-leading position: ANZ Group
Finance

ANZ NZ continues to hold market-leading position: ANZ Group

ANZ NZ holds market-leading position, continues re-platforming: ANZ Group 

Staff reporters 13 Oct 2025